Distinguish MSCs, SVF, blood-cell products and PRP before discussing source, quality and indication.
Quick answer
Adipose-derived and blood-derived products are not interchangeable. Adipose processing may yield SVF or cultured MSCs; blood may be used for cellular products or PRP, which is not automatically an MSC therapy. Compare actual identity, processing, evidence and indication with a physician rather than judging a syringe’s colour.
SVF is a mixed cellular fraction from adipose tissue, not simply another name for selected, culture-expanded MSCs. Harvesting, isolation and culture are distinct. EHL describes adipose-cell processing; confirm the exact product in your proposal rather than infer it from the manufacturer name.
Blood contains multiple cell types and platelets; plasma is its liquid component. PRP concentrates platelets and is not MSC expansion. A blood-derived proposal should identify composition, processing and evidence for its route. Autologous origin alone does not establish universal safety or suitability.
The owner-supplied syringes and separated layers illustrate a processing context. Colour does not establish identity, count, viability, sterility or efficacy. Request product information and available quality documentation from the provider; do not treat the photo as proof of MSC content or success.
For both proposals, compare source, identity, culture status, route, relevant evidence, batch quality and regulatory pathway. There is no universal ranking of adipose versus blood for every goal. Complete information clarifies what needs individual physician review.
Share your goal and relevant history privately with Khun Kim’s team and request a physician explanation of the EHL-related or other provider proposal. Identify the product before comparing quotations. Continue prescribed care and request feasible follow-up after returning home.
Share your goal, history and recent tests privately through the channel provided by the team for physician review. Include eGFR, creatinine and UACR if relevant and available. Do not post medical records in public comments.
Contact Khun KimSupplied photograph of syringes and separated fractions; colour does not establish cell identity · Owner-supplied image; not verification of product identity, licensing or outcomes
PRP is platelet-rich plasma, not cultured MSCs; blood-derived products should not all be labelled stem cells.
No. SVF is a mixed cell fraction; cultured MSC products require defined identity and processing.
No. A photo cannot establish identity or quality; use product information and physician assessment.
5 points • reviewed 2026-11-14
Reviewed and last updated: 2026-11-14
10 sources • every claim is traceable
https://www.ehlbio.co.kr/company/about/
https://www.ehlbio.co.kr/rd/gmp/
https://www.ehlbio.co.kr/company/contact/
https://mohw.go.kr/board.es?act=view&bid=0027&list_no=1483481&mid=a10503000000
https://www.mohw.go.kr/board.es?act=view&bid=0026&list_no=1487217&mid=a10409020000
https://www.ehlbio.co.kr/company/history/
https://www.ehlbio.co.kr/rd/institute/
https://www.ehlbio.co.kr/rd/patent/
https://www.ehlbio.co.kr/conditioned/
https://www.ehlbio.co.kr/immune_cell/
Last updated: 2026-11-14 · This content is for information only and is not medical advice. Consult a qualified doctor before making treatment decisions.
Back to categories